Social Responsibility

Social Responsibility

Social Responsibility

 

Our values

Our values and the behaviours that support them are reflected in the way we do business and are an important differentiator for BTG. They are at the core of our hiring, employee development, and our performance review processes. As the company grows, we invest time and effort to deliberately preserve our values and culture, which are so fundamental to how we operate that we call it our DNA. We incentivise and reward values-based behaviour by including a values-based assessment as part of our appraisal process.  You can read more about our values here.

Our people

We believe every employee plays an important role in bringing products to market and delivering meaningful benefit to patients. We value the skills, experience, and expertise that they bring to our business.

Though our number of employees and facilities has grown, we continue to provide opportunities for all employees to interact with the Leadership Team, including monthly companywide meetings hosted by the CEO connecting employees around the world by video and teleconference.

The results of this year’s employee engagement survey, conducted by the Great Place to Work® institute, showed that 79% of employees feel BTG is a great place to work, up from 70% in 2012. The survey results showed improvement across all 17 categories measured as compared with our 2012 results, including a 6% improvement in employee engagement and a 6% improvement in our overall ‘Trust Index’ score.

Employee development

In line with our company values, BTG is committed to providing employees with development opportunities and an environment that encourages “Continuous Learning”.

Every employee has a training and development plan. The company runs regular Learning & Development programmes overseen by a dedicated team of Learning & Development Specialists, as well as specific training tailored to the needs of our business. Our induction programme, “Bridging the Gap”, is offered globally to introduce new employees to the business and reinforce our values and culture, and new managers are invited to sharpen their leadership skills through our Management Development Programme.

Diversity and discrimination

BTG employs people in more than 20 countries.  These employees come from all walks of life and represent a diverse range of age, race, religion, gender, gender expression and sexual orientation. More importantly, our employees offer a diversity of opinions and perspective. We foster an open and inclusive culture that allows employees to understand and trust each other, and to listen and learn from each other’s experiences. We believe this leads us to better business decisions and more innovative solutions to problems. 

At BTG, we provide a safe work environment and expect employees to treat each other with respect and dignity. We abide by all employment-related laws and regulations of the countries in which we do business.

We expect that all people decisions, including recruitment, development, promotion and compensation, will be based solely upon a person’s ability, experience, behaviour, work performance and demonstrated potential in relation to the needs of the role without regard to unrelated personal characteristics such as race, colour, religion, gender, sexual orientation, age, gender identity, or gender expression, national origin, marital status, disability, veteran status, or other characteristics protected by applicable laws.

We do not tolerate discriminatory behaviour, harassment or retaliation against those reporting or involved in the investigation of claims alleging such behaviours.

Gender diversity data

Number of females who are: 2016/17  2015/16
Employees 678 (48%) 591 (58%)
Senior Managers 71 (34%) 52 (35%)
Leadership Team Members 4 (33%) 3 (25%)
Board Directors 2 (22%) 2 (25%)

In accordance with the UK government’s Equality Act 2010 (Gender Pay Gap Information) Regulations of 2017, BTG has published a number of metrics showing differences in pay between genders. Our analysis suggests these differences are driven by proportionally more men being in some more senior, higher paid roles. The analysis has helped us identify these gaps to better target our efforts to address them. You can read more about our UK gender Pay Gap disclosures here.

Occupational health and safety

We understand our responsibility to protect the health and safety of our employees and conduct regular risk assessments, audits and training. BTG complies with all requirements of local legislation and provide a minimum standard by which all sites will operate in the absence of local legislation. The company maintains strong local relationships with government health and safety bodies.

Our Leadership Team receives a monthly report covering a range of environment, health, and safety metrics, and we regularly remind employees of their obligation to report any incidents to ensure that measures can be taken for improvement. We aim to record all accidents and incidents resulting from work-related activities for anyone engaged by BTG either in full-time employment or as a contractor. This includes activities such as driving on company business and incidents that occur on supplier or customer sites.  We publish Health and Safety incidence rates for our manufacturing sites in our annual report and on this website.

Occupational health and safety data

Data 

2015/16  2014/15  % Change 

Total lost time accidents and illnesses
(days per 100,000 hours worked)9, 10

0.34 0.69 -50%

9 Includes all accidents and illnesses where one or more days are lost. This figure includes accidents where people have returned to work and were given alternative duties as they were not able to fulfil their normal roles.
10 Work-related illnesses included for the first time in 2015. A like for like comparison of lost time attributed only to accidents show rate increase of 10% (0.55 vs 0.50).

Human rights and labour practices

BTG takes its responsibility to protect human rights very seriously. BTG respects numerous international standards including the United Nations Universal Declaration of Human Rights. We have a Human Rights Statement describing the activities that we undertake and defining the companywide standards that we adhere to. This document also summarizes our activities to ensure slavery and human trafficking is not taking place in our business or our supply chain.  We believe this statement aligns with the requirements of the US California Transparency in Supply Chains Act which came into effect at the beginning of 2012, and the UK Modern Slavery Act which came into effect on 1 October 2015.  

Corporate philanthropy

We see charitable giving as an important way to support and build relationships within the communities where we live and work. Each year Corporate Charities are chosen locally by employees at each of our major sites. In accordance with our charitable giving policy, we give to charities that either support diseases or conditions in which we are therapeutically focused or that benefit the local communities in which we operate. BTG encourages employees to support charitable events by matching funds raised by individuals up to a designated cap.

During 2015, we made donations to a number of charities, including:

  • American Heart Association and American Stroke Association (US)
  • Children's Hospital of Eastern Ontario (Canada)
  • Disability Challengers (UK)
  • Frimley Hall Cystic Fibrosis Unit (UK)
  • Great Ormond Street Hospital Children's Charity (UK)
  • HeartKids South Australia and Northern Territory (Australia)
  • Hilfe für krebskranke Kinder e.V. Frankfurt (Germany)
  • MacMillan Cancer Support (UK)
  • St. Jude Children’s Research Hospital (US)
  • The 2015 Ottawa Toy Mountain campaign (Canada)
  • The Roy Castle Lung Cancer Foundation (UK)
  • Tŷ Hafan - the hospice for children in Wales (UK)
  • United Way of Salt Lake City (US)
  • Wales Air Ambulance (UK)

Bioethics

BTG is committed to maintaining high ethical standards in the conduct of our research and development studies. We comply with all applicable laws, the global standards of good practice and the applicable regulatory requirements during the conduct of both clinical (such as Good Clinical Practice, the Declaration of Helsinki) and non-clinical studies (such as Good Laboratory Practice).

The safety and well-being of the patients participating in our clinical trials is our utmost concern. We ensure that the individuals participating in our clinical studies understand the risks involved and why they qualify to take part in a trial, as well as the protection of their personal information and privacy. The provision of written informed consent is of paramount importance. We seek to ensure that participants are not exposed to unnecessary risks. All clinical trial proposals are reviewed and evaluated for scientific merit, both internally, but also with experts in the medical field and external bodies, such as independent review boards (IRBs) or Ethics Committees. During the conduct and analysis of clinical trials, all appropriate confidentiality rules are applied. All information from the research is recorded and stored in ways that both assure compliance with data protection laws and also allow for accurate and transparent verification, interpretation and reporting. Results of BTG’s clinical studies are made available on www.clinicaltrials.gov.

Research involving animals is carefully considered, justified and monitored. The humane care of animals used in our studies is mandatory. Our policy requires that the use of animals in research will be performed to the highest standard of ethics, adhering to the three guiding principles of reduction, refinement and replacement. All animal studies are performed at external Contract Research Organisations and academic units, and we will only work with external parties that evaluate animal studies using a local ethical review process. In addition, we will only perform animal studies in territories where they are strictly regulated. Our Animal Ethics and Welfare committee ensures compliance with these policies.

Access and handling of genetic materials

BTG is at the forefront of the development and application of new scientific techniques to discover and develop new healthcare products. However this does not currently include the use of human genetic material. Therefore, BTG has not defined policies and standards regarding the use of and access to human genetic resources.

  • FTSE4Good index

    BTG is a member of the FTSE4Good index, a leading investment index designed to measure the performance of companies demonstrating strong Environmental, Social and Governance (ESG) practices.

    Learn more FTSE4Goodsml_200PixelsW.jpg